ConCallIQ
Go Pro
CHANDANHEALTHCARE Healthcare 31 Dec 2025

Chandan Healthcare Ltd — Q3 FY26

Chandan Healthcare delivered a solid Q3 FY26 with revenue of ₹65.77 Cr (+20% YoY) and EBITDA of ₹12.61 Cr (+39% YoY), driven by 34% growth in B2C diagnostics.

bullish high
Compare with...
Revenue ₹65 Cr +20%
EBITDA ₹13 Cr +39%
PAT ₹5 Cr +7.97%
EBITDA Margin 18.21% +263bps
Duration 65 min
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Employee Cost Inflation

Employee costs rose to 18% of revenue due to expansion-related hiring and one-time gratuity provisioning; may pressure margins if revenue ramp-up lags.

medium · analyst_question
R

Working Capital Strain from Government Contracts

Although the Punjab project is cash-based, other government contracts may have delayed payments; management acknowledged B2G receivables take 3-4 months.

medium · analyst_question
R

Execution Risk in Rapid Expansion

Opening 18 labs and 7 comprehensive centers in one year, plus a large government project, could strain operational bandwidth and quality control.

medium · data_observation
R

Competition from Organized Players in Franchise Business

Franchise model faces direct competition from Dr. Lal, Thyrocare, and Metropolis; management expects franchise to be only 10% of total business.

low · management_commentary